| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Revenue | $57.40B | +8.4% |
| R&D Expense | $9.86B | +10.6% |
| SG&A Expense | $1.60B | +3.5% |
| Operating Income | $17.68B | +15.1% |
| Interest Expense | $3.58B | +1.8% |
| Income Tax | $1.72B | +34.8% |
| Net Income | $12.44B | +18.9% |
| EPS (Basic) | $4.46 | +16.8% |
| EPS (Diluted) | $4.34 |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.79B | +3.2% |
| Accounts Receivable | $8.56B | +8.7% |
| Inventory | $303.0M | -9.3% |
| Current Assets | $24.58B | +9.0% |
| Total Assets | $168.36B | +19.4% |
| Current Liabilities | $32.64B | +3.5% |
| Stockholders' Equity | $20.45B | +135.0% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.82B | +11.5% |
| Capital Expenditures | $21.21B | +209.0% |
| Investing Cash Flow | -$21.71B | -195.0% |
| Financing Cash Flow | $1.10B | +110.4% |
| Free Cash Flow | -$394.0M | -103.3% |
| +17.0% |